← Back to Clinical Trials
Recruiting NCT06099561

Intractable Self-harm-What Support is Effective?

Trial Parameters

Condition Self-harm
Sponsor Region Skane
Study Type OBSERVATIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-09-01
Completion 2026-12-31
Interventions
National specialized medical care unit for severe self-harm behaviour-Consultation model

Brief Summary

The aim of this project is to evaluate a novel treatment program for individuals with intractable and lethal self-harm. The main questions are: 1: Is there, in individuals with intractable self-harm, a relevant improvement in daily functioning and is this improvement related to the provided interventions? The secondary research questions are: 2\. Is there, in individuals with intractable self-harm, a relevant improvement in frequency and severity of self-harm? 3\. Is there, in individuals with intractable self-harm, a relevant improvement in voluntary hospital admissions? 4\. Is there, in individuals with intractable self-harm, a relevant improvement in compulsary hospital admissions? 5\. Is there, in individuals with intractable self-harm, a relevant improvement in the use of medication pro re nata? 6\. Is there, in individuals with intractable self-harm, a relevant improvement in cost-effectiveness related to the provided interventions?

Eligibility Criteria

Inclusion Criteria: * Having tried or made serious attempt to try at least two different interventions with evidence to reduce self-harm, without sufficient reduction in suffering or self-harm Exclusion Criteria: * Need for translation services to complete measures or interviews * Not able to complete measures or interviews

Related Trials